Atara Biotherapeutics (ATRA) Short-term Investments (2014 - 2025)
Atara Biotherapeutics (ATRA) posted Short-term Investments of $5.4 million for Q2 2025, up 3612.33% on a QoQ basis from $146000.0 in Q4 2024, and up 36.25% year-over-year from $4.0 million in Q2 2024.
Atara Biotherapeutics (ATRA) Short-term Investments (2014 - 2025) Analysis & Trends
Atara Biotherapeutics' Short-term Investments history runs 12 years deep, the most recent figure standing at $5.4 million for Q2 2025.
- Quarterly Short-term Investments rose 36.25% year-over-year to $5.4 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $5.4 million (up 36.25% YoY) and the FY2024 annual result came in at $146000.0, down 99.44% from the prior year.
- Short-term Investments was $5.4 million for Q2 2025 at Atara Biotherapeutics, up from $146000.0 in the prior quarter.
- Across five years, Short-term Investments topped out at $284.1 million in Q1 2021 and bottomed at $146000.0 in Q1 2023.
- A 5-year average of $54.6 million and a median of $1.3 million in 2022 frame the typical range for Short-term Investments.
- Annual changes were most pronounced in 2021 — Short-term Investments jumped 125691.75% — and 2023, when it plunged 99.93%.
- Atara Biotherapeutics' Short-term Investments stood at $194000.0 in 2021, then surged by 77156.19% to $149.9 million in 2022, then plunged by 82.73% to $25.9 million in 2023, then slumped by 99.44% to $146000.0 in 2024, then jumped by 3612.33% to $5.4 million in 2025.
- Business Quant data shows ATRA's Short-term Investments at $5.4 million in Q2 2025, $146000.0 in Q4 2024, and $146000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Atara Biotherapeutics | 110.04 Mn | 101.68 Mn | 392,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 5.42 Mn |
| Dec 31, 2024 | 146,000.00 |
| Sep 30, 2024 | 146,000.00 |
| Jun 30, 2024 | 3.98 Mn |
| Mar 31, 2024 | 11.15 Mn |
| Dec 31, 2023 | 25.88 Mn |
| Sep 30, 2023 | 146,000.00 |
| Jun 30, 2023 | 146,000.00 |
| Mar 31, 2023 | 146,000.00 |
| Dec 31, 2022 | 149.88 Mn |
| Sep 30, 2022 | 1.35 Mn |
| Jun 30, 2022 | 1.35 Mn |
| Mar 31, 2022 | 200.14 Mn |
| Dec 31, 2021 | 194,000.00 |
| Sep 30, 2021 | 244.04 Mn |
| Jun 30, 2021 | 194,000.00 |
| Mar 31, 2021 | 284.06 Mn |
| Dec 31, 2020 | 194,000.00 |
| Sep 30, 2020 | 194,000.00 |
| Jun 30, 2020 | 194,000.00 |